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of home-based rehabilitation for heart 
failure with reduced ejection fraction
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Abstract
Background: Caregivers frequently provide support to people living with long-term conditions. However, there is 
paucity of evidence of interventions that support caregivers in their role. Rehabilitation EnAblement in Chronic Heart 
Failure (REACH-HF) is a novel home-based, health-professional-facilitated, self-management programme for patients 
with heart failure (HF) and their caregivers.
Methods: Based on the random allocation of individual adult patients with reduced ejection fraction (HFrEF) and left 
ventricular ejection fraction <45% within the past five years, the caregiver of patients was allocated to receive the 
REACH-HF intervention over 12 weeks (REACH-HF group) or not (control group). Caregiver outcomes were generic 
health-related quality of life (EQ-5D-5L), Family Caregiver Quality of Life Scale questionnaire (FamQol), Caregiver Burden 
Questionnaire HF (CBQ-HF), Caregiver Contribution to Self-care of HF Index questionnaire (CC-SCHFI) and Hospital 
Anxiety and Depression Scale (HADS). Outcomes were compared between groups at 4, 6 and 12 months follow-up. 
Twenty caregivers receiving REACH-HF were purposively selected for qualitative interviews at 4 and 12 months.
Results: Compared with controls (44 caregivers), the REACH-HF group (53 caregivers) had a higher mean CC-SCHFI 
confidence score at 12 months (57.5 vs 62.8, adjusted mean difference: 9.3, 95% confidence interval: 1.8–16.8, p = 
0.016). No significant between group differences were seen in other caregiver outcomes. Qualitative interviews showed 
that most caregivers who received the REACH-HF intervention made positive changes to how they supported the HF 
patient they were caring for, and perceived that they had increased their confidence in the caregiver role over time.
Conclusion: Provision of the REACH-HF intervention for caregivers of HF patients improved their confidence of self-
management and was perceived for some to be helpful in supporting their caregiver role.
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Introduction
Heart failure (HF) is an unpredictable life-limiting condition 
that is challenging to self-manage. People with HF typically 
experience poor levels of health-related quality of life 
(HRQoL) due to episodes of breathlessness, oedema, fatigue 
and associated anxiety and depression.1 Families and social 
networks frequently support people living with long-term 
conditions, including HF.2,3 Caregivers for people with HF 
have identified three distinct needs: (1) supporting HF man-
agement, including coping with the variability of HF symp-
toms, understanding and managing medicines, providing 
emotional support, promoting exercise and physical activ-
ity; (2) developing the caregiver role, including communi-
cating with health professionals, managing their own 
well-being; and (3) developing skills to engage social sup-
port, and voluntary and services while recognizing that the 
long-term future may uncertain.4,5 However, there is cur-
rently a paucity of evidence on interventions that support 
caregivers of people with HF in their role.6–9
Home-based programmes can widen access to cardiac 
rehabilitation (CR) and have been shown to be as effec-
tive as centre-based models for people after myocardial 
infarction and coronary revascularisation.10,11 Moreover, 
home-based programmes also have greater potential to 
involve the caregivers in the rehabilitation process and 
offer them support. Rehabilitation EnAblement in Chronic 
Heart Failure (REACH-HF) is a de novo rehabilitation 
self-management programme for patients with HF and 
their caregivers. The REACH-HF intervention is novel in 
a number of ways: (1) theory-based; (2) co-developed 
with stakeholders (patients, caregivers, clinicians, service 
providers); (3) based on intervention mapping; (4) deliv-
ered in home-based setting (in contrast to the traditional 
hospital/centre-based venue) by trained health-profes-
sionals; and (5) and directed at both patients with HF and 
their caregivers.12–14
A multicentre randomized controlled trial has shown 
that, compared to usual care alone, the addition of the 
REACH-HF intervention improves the disease-specific 
HRQoL of people with HF with reduced ejection fraction 
(HFrEF) and is a cost-effective use of healthcare 
resources.15,16 The aims of this paper are twofold: first, to 
compare the caregiver outcomes between the REACH-HF 
and control groups; second, to report the views and per-
ceptions of caregivers on their experience of using the 
REACH-HF intervention.
Methods
Study design
The published protocol provides a full description of the 
trial design and procedures.12 In summary, men and women 
aged ⩾18 years with a confirmed diagnosis of HFrEF on 
echocardiography or angiography (i.e. left ventricular 
ejection fraction <45% within the preceding five years) 
were recruited from primary and secondary care settings in 
four centres in the United Kingdom (Birmingham, 
Cornwall, Gwent and York). At study entry, patients were 
asked to nominate if they had a caregiver, i.e. a spouse, 
other relative or friend, who provides unpaid support to 
patients. Unpaid support includes emotional support, 
prompting with taking medications, observing for signs 
and symptoms of HF, getting prescriptions, encouraging 
participation in social events and physical activity, helping 
with household tasks or providing physical care.
Patients were randomly allocated in a 1:1 ratio, strati-
fied by investigator site and baseline plasma N-terminal 
proB-type natriuretic peptide levels (⩽2000 vs >2000 pg/
ml), using minimization to facilitate balance between the 
groups. Randomization numbers were computer generated 
and assigned in strict sequence at the point of randomiza-
tion. To maintain concealment, the Peninsula Clinical 
Trials Unit used a password-protected, Web-based rand-
omization system to allocate participants after consent was 
obtained and baseline assessment data entered. Caregivers 
were allocated to receive the REACH-HF intervention 
(REACH-HF group) or not (control group) in accord with 
the random allocation of their patient partner.
The investigation conformed to the principles outlined 
in the Declaration of Helsinki and was approved by the 
North West Lancaster Research Ethics Committee (14/
NW/1351). Written informed consent was obtained from 
both patient and caregiver participants.
REACH-HF intervention
A detailed description of the REACH-HF intervention, its 
development including extensive consultation and involve-
ment of our patient and public involvement group and its 
theoretical underpinnings is published elsewhere.14
The REACH-HF intervention is a comprehensive, 
evidence-informed, patient-centred, theory-based, self-
care support programme that includes four core 
elements:12,14,15
•• ‘REACH-HF manual’ – providing information on: 
(1) understanding HF, (2) managing HF in terms of 
including change of lifestyle key self-care targets 
(building physical fitness through exercise, manag-
ing fluids, managing medications and managing 
stress/anxiety/low mood) and (3) living with the 
uncertainty of HF.
•• ‘Progress tracker’ – allows patients to record symp-
toms, physical activity and other actions related to 
self-care; this was designed to act as a ‘scaffold’ to 
aid reflection on progress, increase their under-
standing of how self-care actions affect their physi-
cal and mental wellbeing, and adapt their self-care 
strategies over time.
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•• ‘Family and friends resource’ – for use by caregiv-
ers, including advice on providing support, becom-
ing a caregiver, managing the caregiver’s own 
health and wellbeing and getting help.
•• Facilitation by cardiac nurses or physiotherapists, 
including assessment of individual patient and car-
egiver needs and concerns and tailoring of the inter-
vention content to address these; this element was 
supported by a three-day training course for facilita-
tors on how to deliver the intervention using a 
patient-centred style of communication.
The intervention was delivered at the patient’s home via 
a mixture of face-to-face and telephone contacts over 12 
weeks (typically 4–6 contacts). During home visits and tel-
ephone follow-up, facilitators supported the participants 
and caregivers to understand and manage HF, set goals and 
develop self-care strategies.15 Facilitators were asked to 
spend time with the caregivers to help them understand 
how best to support the patient, as well as to look after 
their own wellbeing.
Outcomes and interviews
Caregiver outcomes included the Hospital Anxiety and 
Depression scale (HADS),17 generic HRQoL (EQ-5D-5L 
questionnaire),18 Family Caregiver Quality of Life 
(FamQol),19 Caregiver Burden Questionnaire for Heart 
Failure (CBQ-HF),20 and Caregiver’s Contribution to Self-
care of HF Index (CC-SCHFI).21 Outcome data were col-
lected during three clinic visits at baseline, four and 12 
months, and by postal questionnaire at six months. At the 
baseline clinic visit, sociodemographic data was also col-
lected. Data was collected by research nurses who were 
blinded to group allocation.
Twenty caregivers in the REACH-HF group were 
selected for interview at 4 and 12 months using maximal 
variation sampling that took account of patient and car-
egiver baseline HRQoL scores, caregiver demographics 
(age, gender and ethnicity), and geographical location. 
Home interviews were conducted by two experienced 
qualitative researchers (JW, Lucy Moore). Caregivers 
were encouraged to describe their views and experiences 
of the REACH-HF intervention. Interviewers were guided 
by answers from the interviewees and used further probing 
questions such as ‘tell me more about …?’ Other tech-
niques to enhance the interview included reflecting on 
what was said and using non-verbal communication to 
show that the researcher was actively listing. Interviewers 
summarized the content of the interview at the end of the 
discussion and invited the participant to add anything else 
they wanted to share. The interview topic guide 
(Supplementary table 1) was reviewed throughout the 
study so that the questions were informed by relevant 
emerging topics, e.g. the impact of roles outside the home 
and the difficulties encountered by caregivers who did not 
live with the cared for person. Interviews were audio 
recorded and researchers wrote field notes at the end of 
each interview detailing observations of the home and 
social context; reflections on researcher performance and 
potential influence on the interview; how the participant 
responded to the questions; and initial thoughts about the 
main points arising from the interview.
Data analysis
The sample size of the study was based on a minimal clini-
cally important difference (5 points) in the HF patient pri-
mary outcome measure (Minnesota Living with Heart 
Failure Questionnaire) and assumed attrition rate of 10%. 
At type I error of 0.05 and power of 90% this required a 
total of 108 patients per group were required. The was no 
formal sample size calculation for the number of caregiv-
ers participating in this study.
Quantitative analysis. All statistical analyses were con-
ducted to a predefined analysis plan agreed in advance 
with the trial management group, Trial Steering committee 
and Data Management committee. Caregiver outcomes are 
reported descriptively by group at all assessment points 
(baseline, and 4 and 12 months follow-up). REACH-HF 
and control group caregiver outcomes are compared at 
12-months using linear regression methods, adjusting for 
baseline score. All between-group outcome comparisons 
are presented intention-to-treat basis (i.e. according to 
group allocation at baseline) in caregivers with complete 
outcome data at 12 months and are reported as mean dif-
ferences with a 95% confidence interval (CI). No imputa-
tion for missing data was undertaken. Analyses were 
undertaken by the trial statistician (FCW) who was blinded 
to group allocation and according to a predefined analysis 
plan using Stata version 14.1. No interim analyses were 
performed.
Qualitative analysis. A thematic analysis was conducted 
by two experienced qualitative researchers (JW and JF).21 
Interview audio tapes were transcribed verbatim. The 
data set included: facilitator contact sheets, baseline 
questionnaire data, field notes, and interview transcripts. 
Data was managed by NVIVO 11 Pro. Sections of data 
related to the aims were assigned a code that summarized 
the content either descriptively or interpretively. Codes 
with common features were grouped together in emerg-
ing themes, before finally being assigned to overarching, 
interpretive themes. Constant comparative techniques 
were used to compare individual 4- and 12-month inter-
views and across all caregiver participants’ interviews.22 
An additional analytical memo note was used to note and 
test early hypotheses and explore emergent hypotheses 
from the data.
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Results
Study sample
Between January 2015 and February 2016, 216 HFrEF 
patients were randomly allocated to the REACH-HF 
group (n = 107) and control group (n = 109). A total of 
97 patients declared a caregiver - 53 caregivers in the 
REACH-HF and 44 in the control group. At 12 months, 
outcomes data was available from 45 (85%) caregivers 
in the REACH-HF group and 37 controls (84%) (see 
Figure 1).
Baseline characteristics
Caregivers were typically the partner or direct relative, 
were of a younger mean age than participating patients and 
predominantly female. There was evidence of imbalance 
in caregiver baseline demographic characteristics and out-
come scores between groups; controls were older and had 
higher levels of depression and anxiety and lower generic 
HRQoL (Tables 1 and 2).
Outcomes
There was evidence of improvements from baseline at 4, 6 
and 12 months follow-up in a number of caregiver out-
comes in the REACH-HF group, including HADS-anxiety, 
CBQ-HF physical, social life and lifestyle and all SCHFI 
dimension scores. Compared to controls, the only signifi-
cant difference was in mean CC-SCHFI confidence score 
at 12-months (57.5 vs 62.8, adjusted mean difference: 9.3, 
95% CI: 1.8–16.8, p = 0.016. Table 2 shows the outcome 
means and standard deviations in both groups.
Interviews
One caregiver declined to be audio recorded and was 
excluded from the analysis. The 19 caregivers who agreed 
to be interviewed had similar demographic characteristics 
to the overall study cohort of caregivers (Supplementary 
table 2). All 19 caregivers were interviewed at four months 
and 16 were interviewed at 12 months (one withdrew as 
her husband was unwell and two declined to take part). 
The majority of interviews were conducted in the patient’s 
Figure 1. CONSORT flow diagram.
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home (usually with the patient present) and the average 
duration of interviews was 51 min (range 15–103) and 43 
min (range 13–100) at 4 and 12 months respectively.
Two overarching themes emerged from interviews: (1) 
engagement with the REACH-HF intervention and (2) 
impact on caregiver role. These themes and related sub-
themes are described below.
Theme 1: engagement with the REACH-HF intervention
Expectations. and hope
Most caregivers spoke of hope that the cared for person 
would make changes in lifestyle or have professional guid-
ance on how best to manage HF and what to do in an 
emergency.
My goal is that he keeps it [heart failure] off, and keeps himself 
healthy, because we have discussed the only alternative. That 
if he's unable to look after my mum, the most horrendous thing 
that could happen to them both is that mum has to be put in a 
home or something like that, and he can't bear that.
(Male caregiver – son, aged 49 years)
Few caregivers had expectations for their own health and 
wellbeing but most expressed feeling valued as they were 
included in the intervention.
Engagement with the intervention. While many caregiv-
ers did engage with the intervention, there was evidence 
that some caregivers actively chose to not engage with the 
Table 1. Characteristics of caregivers and HF patients they care for.
REACH-HF group Control group
 (n = 53) (n = 44)
Caregivers
Gender: female, n (%) 43 (81) 33 (75)
Age: years, mean (SD) 62.8 (14.7) 68.2 (11.3)
Relationship to patient: n (%)  
 Spouse/partner 44 (83) 36 (82)
 Direct family 5 (9) 6 (14)
 Other relative 1 (2) 1 (2)
 Friend 3 (6) 1 (2)
Employment status: n (%)  
 Employment/self-employment 15 (28) 6 (14)
 Retired 35 (66) 33 (75)
 Housework 2 (4) 0 (0)
 Unemployed 1 (2) 3 (7)
 Other 0 (0) 2 (5)
Location: n (%)  
 Birmingham 6 (11) 8 (18)
 Cornwall 19 (36) 14 (32)
 South Wales 13 (25) 10 (23)
 York 15 (28) 12 (27)
Patientsa
 Gender: female, n (%) 13 (25) 9 (20)
 Age: years, mean (SD) 69.4 (10.9) 71.3 (10.3)
Employment status: n (%)  
 Employment/self-employment 7 (13) 3 (7)
Retired 43 (81) 36 (82)
Housework 0 (0) 1 (2)
Unemployed 2 (4) 1 (2)
Other 1 (2) 3 (7)
Living alone, n (%) 6 (11) 3 (7)
NYHA: n (%)  
 Class I 11 (21) 8 (18)
 Class II 29 (55) 25 (57)
 Class III 13 (25) 11 (25)
 Class IV 0 (0) 0 (0)
Ejection fraction: mean (SD), n 31.0 (8.8), 40 31.3 (8.6), 34
aDemographic and clinical characteristics of HF patients with caregivers.
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facilitator and obstructed facilitator efforts to engage. Pro-
active engagement was enhanced when the patient made 
perceived improvements in HRQoL, especially if there was 
an improvement in social activities. These engaged car-
egivers were also more likely to have a wider close social 
support network, and there are examples where the ‘family 
and friends resource’ as shared with this social network. 
Conversely, fear of hospitalization of the cared for person 
could also act a factor motivating active engagement.
The manual was on the table and shows signs of wear and has 
post it notes on it. She has from time to time looked at it for 
referral and comfort. She could not recall a specific example 
but the look of the manual shows someone is using it. The 
Family and Friends resource also had book marked sections 
– symptoms and what to do in an emergency and when to call 
for help. There was a sense of being prepared for an emergency 
which I reflected back to her and she agreed.
(Field notes: Female caregiver – wife aged 74)
Factors influencing non-engagement or limited/passive 
engagement. Those caregivers who had a good relation-
ship with an existing nurse or health professional were less 
likely to see the need for the intervention or to understand 
that the intervention could be used to address their own 
health and wellbeing. Employed caregivers had no or lit-
tle facilitator contact. One facilitator attempted on multi-
ple occasions to contact a caregiver but the caregiver did 
not return the calls, and this obstructed engagement. Non-
engaged caregivers often felt they already had the knowl-
edge and skills they required.
When [wife] went for consultations at the hospital or with the 
[surgeon], with the doctors and everything, generally I was 
there. So I knew what they [facilitator] had to say and what 
their opinions generally were. And we had information 
anyway about the heart conditions because we get this, 
(British) Heart Foundation magazine, which is really quite 
interesting. I’m not really a novice in the game if you like and 
haven’t been really from the start.
(Male caregiver – husband, aged 84)
Resource use. All sections of the REACH-HF family and 
friends’ resource were used by at least one caregiver and 
the most used sections related to managing signs and symp-
toms, what to do in an emergency and when to call for help.
I think there’s – in there there’s a website for um carers … and 
you think ‘Well, hang on a minute, yeah, there are other 
people out there and they all understand exactly how you 
feel’. Isolated, I suppose, that’s the word, I don’t feel so 
isolated anymore.
Impact of research processes. An unexpected finding 
was the significance of the caregiver questionnaires used 
to collect baseline quantitative outcome data in the trial 
research nurse appointments. The HADS and HRQoL out-
come questionnaires acted as a ‘stop and think’ moment to 
reflect for the first time on the impact of being caregivers. 
Some reported that as a result they were more honest when 
completing the questionnaire at the follow-up data collec-
tion points.
It was bang on the money but there was no reference to that 
throughout the… [Intervention]. Throughout the study. If that 
was, if that could be a constructive criticism. 
………………………………But that questionnaire was perfect.
(Male caregiver – husband aged 45)
Theme 2: impact on caregiver role. When asked about their 
role, there were two distinct groupings: (1) caregivers who 
were proactive or ‘enabling’ in supporting self-manage-
ment activities and (2) caregivers who believed the locus 
of control for self-management should be with the cared-
for person. As a result of the REACH-HF intervention, 
some caregivers adopted a more supportive role using the 
advice in the ‘Family and Friends Resource’ to discuss 
how the person was feeling and then agree a mutual man-
agement plan.
Informed vigilance. Most caregivers also spoke of the 
importance of knowing the individual and looked for facial 
clues such as pallor and dullness of eyes. Vigilance was 
often reported as a constant covert activity that could be 
enhanced by REACH-HF.
Because, with the heart failure manual it tells you what to 
look out for. When you first have got heart failure you don't 
know what to look out for. It's that you've got no signs, you've 
got no reference, but with the manual there is that little bit of 
reference there that says, this is what you need to do. You need 
to seek medical attention ASAP. Basically that's what it's 
telling you.
(Female caregiver – wife, aged 41)
Relationship with cared-for person. The intervention was 
more effective when the couple appeared to have an open 
honest relationship about the impact of HF, its manage-
ment and outlook for the future. Two of the adult children 
reported role reversal making the encouragement of self-
management activities difficult.
Supporting physical activity. The REACH-HF walking 
programme was seen as an opportunity to get out socially, 
as well as to get some exercise for those caregivers who 
walked with the cared-for person. At 12 months, the 
minority who had experienced a significant health setback 
for the cared-for person, spoke confidently of restarting 
the exercise programme.
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It’s given me a pathway to take her down. And, as far as I’m 
concerned, your programme, it gave me something to do at 
the time it was needed, but it has also given me something I 
can do in the future. So your programme is brilliant because 
it…, has given us a way forward and an improving way 
forward for when it happened. And now we’ve got the 
resources that, already on hand that we know, that we can use 
again, time and time as required.
(Female caregiver – friend, aged 68)
Supporting emotional and stress management. Those car-
egivers who had an open relationship or reported getting 
closer were also more likely to support each other emo-
tionally.
Supporting medication management. Many caregivers 
read the medication sections of the manual and there was 
evidence of learning about side effects, dietary interac-
tions, preventing flu and over the counter remedies.
I didn’t actually know that he shouldn’t really be having 
spinach and green leafy vegetables, because they’re blood 
thinners and don’t go with the warfarin. I don’t think I’d ever 
been told that before, so that was something that I didn’t 
know. And things like when to… When you really should be 
contacting the heart nurse or the surgery and when you can 
try to do things yourself, like taking an extra Furosemide, if 
needed.
(Female caregiver –wife, aged 65)
Impact on caregiver health. There was a strong link 
between the health of the caregiver and the health of the 
HF patient. However, caregivers made few changes to 
management of their own health.
I’ve always, well I joined the gym when I retired anyway, you 
know, but you go into these phases where you’re going or not. 
And I stopped going because [husband] wasn’t all that well 
and my daughters had said to me, ‘Mum, you’ve got to start 
doing things for yourself.’ So, sort of, you know, encouraged 
by them and then I thought, ‘Right, this [resource], It’s almost 
like gives you permission, like it’s okay to do this.’
(Female caregiver – wife, aged 64)
Discussion
We report the impact on caregivers of REACH-HF – a 
novel, home-based, self-management intervention aimed 
at both HF patients and their caregivers. Compared to con-
trol, there was no significant difference in caregiver out-
come with exception of CC-SCHFI confidence score. 
However, our qualitative research showed that most car-
egivers who received the REACH-HF intervention, made 
positive changes to how they supported the HF patient 
they were caring for, and perceived that they had increased 
their confidence in the caregiver role.
Our findings provide important evidence of the impact 
of a rehabilitation and self-management intervention for 
HF patients on caregiver outcomes. We know of only one 
previous randomized trial that was undertaken in a single 
centre UK setting. Witham et al assessed a 24-week exer-
cise-based CR intervention in functionally impaired elderly 
(⩾70 years) HF patients.23 Compared to no exercise con-
trol, the authors reported no significant difference at 8 or 24 
weeks in either patient or caregiver outcomes. Caregiver 
outcomes collected were similar to the present study, i.e. 
mental wellbeing (HADS anxiety and depression) and bur-
den/strain (Zarit Burden Interview). Whilst the Witham 
trial encouraged caregivers to involve themselves in the 
exercise training sessions of patients, there was no mention 
of involvement of caregivers in the intervention develop-
ment or delivery (only 10/71 caregivers in the trial accepted 
the invitation to participate in the exercise programme). In 
contrast, the REACH-HF intervention was co-designed 
with several stakeholders, including caregivers, and 
included a formal element of the intervention (‘family and 
friends resource’) specifically aimed at caregivers.
Strengths of this study included its multicentre design, 
collection of a range of questionnaire-based outcomes 
intended to assess mental wellbeing, burden and HRQoL 
of caregivers, and the mixed methods design that included 
in depth interviews with caregivers. However, this study 
has some important limitations that may explain the lack 
of quantitative differences between the intervention and 
control groups. First, baseline mean HADS depression, 
Fam-Qol and CBQ-HF scores indicated consistently good 
levels of caregiver functioning and, therefore, little room 
for further improvement. Second, caregivers were not 
themselves randomized to intervention and control groups, 
increasing the risk of selection bias and cofounding in the 
comparison of REACH-HF and control groups. Third, 
given the primary aim of the trial was to assess the impact 
of REACH-HF on HF patients, the study sample size was 
powered on the between-group difference in patient rather 
than for caregivers. For example, if we had powered the 
trial based on detection of a minimum clinically important 
difference for the HADS score of 1.4 would have required 
a sample size of 227 caregivers per group (at 90% power 
and 5% alpha).24 As this minimum clinically important dif-
ference lies well inside the 95% CI for the between-group 
difference in HADS anxiety and HADS depression seen in 
the current study at 12 months, we cannot rule out a clini-
cally important effect of REACH-HF intervention upon 
caregivers. Finally, our trial process evaluation found that 
healthcare staff facilitating the REACH-HF intervention 
appeared to be less effective in involving of caregivers 
than patients.
There is a growing interest in including caregivers in 
intervention delivery.2–4 One of the key implications of this 
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study is the need to better engage caregivers in rehabilita-
tion and self-management interventions for HF patients. 
We recognize that actively working with caregivers may 
have been a new experience for many of the healthcare 
facilitators who participated in this trial and we are cur-
rently making adaptations to reflect this in our REACH-HF 
facilitator training. A structured caregiver assessment tool 
may assist facilitators to plan and deliver this aspect of the 
intervention.12 Further high quality evidence is required to 
confirm the benefits of actively involving caregivers in the 
development and delivery of rehabilitation and self-man-
agement interventions for HF and other chronic diseases.
Implications for practice
•• There are few evidence-based interventions to 
support caregivers for people with chronic 
disease.
•• Provision of the Rehabilitation EnAblement in 
Chronic Heart Failure (REACH-HF) interven-
tion for caregivers of patients with heart failure 
may improve their confidence to support self-
management and was perceived to be helpful in 
maintaining their role as caregivers.
•• Refinements of the REACH-HF intervention 
have been made ahead of its roll out into the UK 
National Health Service, including strategies to 
better target caregivers.
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